Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) today and set a ...
In a report released yesterday, Vijay Rakesh from Mizuho Securities reiterated a Buy rating on Credo Technology Group Holding Ltd (CRDO – ...
Humana Inc. (the "company") (NYSE: HUM) announced today the completion of its public offering of $1.25 billion in aggregate ...
Securities adjusted its outlook on Albemarle Corporation (NYSE:ALB), a leading producer of lithium, by reducing its price target from $105.00 to $90.00, while keeping a Neutral rating on the stock.
State Street Corporation (NYSE: STT) and Mizuho Financial Group, Inc. (President & Group CEO: Masahiro Kihara) today ...
The Japan Fair Trade Commission on April 13 rebuked Mizuho Securities Co. for setting initial public offering (IPO) prices of newly listed stocks too low, which could lead to violating the Anti ...
A Mizuho analyst has brought back his coverage of Super Micro shares — but declines to recommend them, citing competitive ...
1d
Hosted on MSNSunnova Stock Dims After-Hours As Analysts Downgrade On Going-Concern Warning, But Retail Still Sees A Ray Of LightShares of Sunnova Energy International Inc. (NOVA) fell more than 3% during after-market trade on Tuesday after analysts at ...
The deal also offers a subordination piece that represents 14% of the pool balance, helping to boost the credit to the notes.
PENN Entertainment (NASDAQ:PENN – Free Report) had its price objective raised by Mizuho from $24.00 to $25.00 in a research ...
The decline of Coinbase’s stock mirrors a nose dive in the price of Bitcoin. The world’s largest cryptocurrency dropped 17% ...
Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.25 billion in aggregate principal amount of senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results